CRISPR Therapeutics AG | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (36)

Latest Posts

About This Stock More About This Stock
Top CRISPR Stocks
Article By: Fred Fuld III
Saturday, February 11, 2023 9:09 PM EDT
CRISPR is a narrow niche of the biotechnology industry, but it could become the fastest growing and most significant of all the biotech businesses.
In this article: EDIT, NTLA, CRSP Also: NVS
Read
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
Article By: Rod Raynovich
Sunday, February 5, 2023 8:10 PM EDT
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?
In this article: NTLA, IBB, PACB, XBI, SUPN, CRSP, ARKG, VCYT Also: CYRX, GERN, QDEL, HOLX, VRTX, EXAS, EVH, NVTA, TDOC
Read
Small Cap Biotech Stocks Are Trending Well
Article By: Rod Raynovich
Monday, July 18, 2022 4:14 AM EDT
Despite a little weakness last week, small cap biotechs are trending well for traders. For investors entering the trade on July 5 all of our. focus stocks are up except ChemoCentryx.
In this article: REGN, PACB, EXAS, XBI, MRNA, TDOC, CRSP, ARKG, VCYT
Read
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Article By: Rod Raynovich
Wednesday, June 22, 2022 5:36 AM EDT
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma.
In this article: LLY, UNH, XLV, CRSP Also: CCXI, EVH, MRTX, MDGL, VCYT
Read
Crispr: A Fallen Angel In Gene Editing
Article By: MoneyShow.com
Friday, October 15, 2021 11:31 PM EDT
As with most promising biotech companies, investors bid their prices up for CRSP based on its potential for early profits. When the payoff didn't occur on schedule, investors bailed out. Once it becomes profitable, investors will come flocking back.
In this article: CRSP Also: NVAX, VRTX, RHHBY, AMGN, BIIB, GILD
Read

Latest Tweets for $CRSP

No tweets yet!

PARTNER HEADLINES